AliveCor KardiaMobile 6L ECG
US$ 179 Price in USD — free shipping included
Independent profile. MedikalDevice is not affiliated with its manufacturer. Specifications come from public manufacturer documentation — confirm FDA status for your intended use. How we verify profiles.
Personal 6-lead ECG device with three electrodes: two thumbs on top and one electrode on the left knee or ankle. It records a 30-second single-lead or six-lead ECG and sends it to a smartphone app for analysis. Sold over the counter for consumers and also used by clinicians.
Key facts
| Product | KardiaMobile 6L |
|---|---|
| Manufacturer | AliveCor, Inc. |
| Intended users | Professional and home use |
| US FDA status | 510(k) cleared — K210753 |
| Market status | Available |
Main features
- Three electrodes; records 1-lead or 6-lead ECG
- 30-second recording
- Instant Analysis: normal sinus rhythm, atrial fibrillation, bradycardia, tachycardia, unclassified
- Kardia AI V2 adds sinus rhythm with PVCs, with supraventricular ectopy (SVE) and with wide QRS
- Replaceable CR2016 coin-cell battery
- Not intended for pediatric use
Connectivity
Bluetooth to the Kardia app (iOS/Android); clinician access through AliveCor's KardiaPro platform.
AI and analysis software
KardiaAI rhythm-analysis platform (Instant Analysis); Kardia AI V2 algorithm suite (FDA-cleared November 2020) for KardiaMobile and KardiaMobile 6L.
Software outputs are an aid to the clinician, not a diagnosis, and are limited to the indications cleared for each feature.
Regulatory status in the United States
FDA 510(k) clearance: K210753. First cleared May 2019. K210753 (June 2021) added QT interval measurement by healthcare professionals. The Kardia AI V2 determinations were cleared in November 2020.
Related guide: How to Read an ECG Output Like a Pro: The Complete Professional Guide.
Sources
Profile verified against public sources in October 2026. Trademarks belong to their owners.
